New Study Shows ImmunoCellular Therapeutics' Lead Investigational Cancer Vaccine ICT-107 Targets Cancer Stem Cells
Scritto da Cancer/Oncology News From Medical News Today   
OncologiaImmunoCellular Therapeutics (OTC.BB: IMUC) today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs)...
Fonte: Cancer/Oncology News From Medical News Today
 

Aggiungi commento


Codice di sicurezza
Aggiorna